Healthcare real estate can look boring until you combine an aging population with a serious shortage of modern care facilities.
Add a company with low leverage and aggressive acquisition capacity, and that boring business can suddenly grow much faster. One mid-cap REIT just made its biggest move yet into that opportunity.
Growth Picks (Sponsored)
Many investors are seeing solid gains in today’s market, but solid gains often hide opportunities with far greater potential.
A new analysis highlights the 5 Stocks Set to Double, selected from thousands of companies showing early signs of powerful growth.
These picks feature strong fundamentals and technical indicators that often appear before meaningful upside.
Past editions of this research uncovered gains of +175%, +498%, and +673%.
Download the 5 Stocks Set to Double. Free Today.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
What Just Happened
CareTrust REIT, Inc. (NYSE: CTRE) agreed to acquire 45 newly built or under-construction U.K. care homes from LNT Care Developments for approximately £1.1 billion, or roughly $1.4 billion.
The first 24 properties were acquired for about £576 million, or $764 million, with the remaining 21 expected to close gradually through 2027 as construction and regulatory approvals are completed.
This is a major transaction for a company recently valued around $8.5 billion, but management did not stop there. CareTrust also raised full-year normalized FFO guidance to $2.06 to $2.09 per share and normalized FAD guidance to $2.02 to $2.05.
The company has now completed approximately $2.7 billion of investments during 2026, already well above the $1.8 billion deployed during all of 2025.
The Deal Has An Unusual Structure
The interesting part is not simply that CareTrust is buying more nursing properties.
During the initial lease-up period, the homes will operate under traditional triple-net leases with Crystal Care. That means the operator handles expenses such as property taxes, insurance, and maintenance while CareTrust collects contractual rent with annual escalators.
That structure gives you relatively predictable rental income while newly built homes fill with residents.
Once the properties stabilize, CareTrust plans to transition them into a senior housing operating portfolio, or SHOP, structure. Instead of simply receiving rent, CareTrust will participate more directly in the underlying economics of the care homes.
That creates more upside if occupancy and operating margins rise, but it also gives CareTrust more exposure to operating performance.
Management expects the first properties to begin making that transition by late 2027 and is targeting initial pre-tax yields in the mid-to-high 7% range once the homes enter the SHOP model.
The deal therefore starts more conservatively and becomes more growth-oriented as the properties mature.
The U.K. Opportunity Could Get Much Bigger
The 45 properties are new, purpose-built, private-pay facilities. LNT has developed more than 250 care homes and currently builds roughly 30 annually.
CareTrust believes the U.K. has a shortage of modern care beds, particularly facilities with private rooms and updated amenities.
The relationship could also extend well beyond these first properties. CareTrust received an option to acquire the entire LNT platform in the future, while management has talked openly about supporting the development of hundreds of additional homes over the coming decade.
That turns this from a one-time property purchase into a potentially much larger pipeline.
And CareTrust is not depending only on LNT. Management says it still has approximately $525 million of near-term investment opportunities outside the remaining 21 homes already under contract.
The acquisition machine is clearly still running.
The Existing Business Is Already Growing
CareTrust entered this expansion from a position of strength.
Second-quarter normalized FFO increased 19% to $0.51 per share, while normalized FAD also rose 19% to $0.51.
The company collected 100% of contractual rent and interest during the quarter.
It also closed nearly $900 million of Q2 investments at a blended stabilized yield of 8.9%, followed by another $308 million shortly after quarter-end.
That matters because the U.K. deal is not being used to rescue a stagnant portfolio. CareTrust was already growing quickly before announcing it.
Management's latest guidance implies normalized FFO growth of roughly 17% at the midpoint compared with 2025.
That is unusually strong growth for a healthcare REIT.
Would you rather own the index, or try to beat it and risk underperforming?
Momentum Builds Here (Sponsored)
A newly released report highlights seven stocks chosen for their near-term potential.
Selections are based on a mix of technical and fundamental indicators.
While past picks have performed well, future results are uncertain.
The report is available for a limited time.
Access the free report.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
The Balance Sheet Makes The Expansion Possible
CareTrust's biggest advantage may be its conservative leverage.
Net debt stood at just 1.01 times annualized normalized run-rate EBITDA at the end of Q2.
Many REITs operate with substantially more debt.
Management deliberately kept leverage below its long-term target so it would have capacity when attractive acquisitions appeared. The LNT deal is exactly the kind of opportunity that strategy was designed to fund.
CareTrust financed the initial acquisition using proceeds from previously arranged equity sales along with its revolving credit facility.
Equity issuance does increase the share count, so you need new investments to earn enough to offset dilution. So far, management expects the LNT transaction to be accretive to normalized FFO per share even during the initial lease-up period.
That is the important test.
Growth only creates value if per-share earnings rise with it.
The Dividend Adds Another Return Driver
CareTrust currently pays a quarterly dividend of $0.39 per share, equal to $1.56 annually.
At recent prices, that gives you a yield a little above 4%.
The Q2 payout represented roughly 76% of normalized FAD, leaving a reasonable cushion for acquisitions and future dividend growth.
This makes the stock an interesting hybrid.
You get an above-market income stream today, but the bigger attraction is the possibility that FFO continues growing at a double-digit pace as billions of dollars of new properties enter the portfolio.
That combination is much more attractive than owning a high-yield REIT with little earnings growth.
What Could Trip It Up
The biggest risk is execution. CareTrust is deploying capital extremely quickly, and the U.K. deal adds international operating, regulatory, currency, and labor exposure.
The SHOP strategy also carries more operating risk than collecting rent under a traditional triple-net lease. If occupancy or margins disappoint, returns could fall below expectations.
Finally, CareTrust relies heavily on access to both debt and equity markets. Higher interest rates or a weaker share price can make future acquisitions more expensive.
Tax Strategy (Sponsored)
Many investors overlook deductions that could help minimize capital gains tax, such as:
Eligible investment expenses
Selling costs tied to property
Each comes with IRS rules and reporting requirements. That’s why consulting a fiduciary financial advisor is often recommended.
My Take
Buy at current levels for income and growth. CareTrust combines a 4%+ dividend with unusually strong FFO growth, low leverage, and a record acquisition pipeline.
The LNT partnership also gives the company a credible path to become a much larger player in U.K. senior housing.
The key risk is capital allocation. Management is investing billions at a rapid pace, so those properties need to earn attractive returns without excessive dilution.
I would watch FFO per share and leverage more closely than the headline size of future acquisitions.
Action Recap
🏥 Looking to buy? Buy at current levels for a mix of income and growth.
📈 Already own it? Keep holding while FFO per share rises and leverage stays conservative.
⚠️ Main risk to respect: Rapid expansion only works if new properties earn enough to offset equity dilution and higher operating complexity.
You Read This Far. Here's Where the Real Work Lives.
We run three live portfolios on Autopilot, and everything about them is public: every position, every allocation, every trade, visible the moment it happens.
We keep our own money in each one, because analysis you won't fund yourself is just content.
THE UNBREAKABLE STACK
Our growth book: durable software and cybersecurity names built to compound quietly for years.
THE HORMUZ PREMIUM
Our energy thesis: built for how that sector actually pays, over quarters, not headlines.
THE SQUEEZE
The defensive sleeve: staples and steady compounders, boring on purpose, built for the nights you'd rather sleep than watch futures.
And here's the part that makes it effortless: Autopilot does the trading for you. Connect the brokerage you already use (Robinhood, Schwab, Fidelity, and more) and every move we make gets mirrored in your own account automatically.
Your money never leaves your brokerage. It stays in your account, under your control, and you can override any trade or disconnect anytime. Autopilot even rebalances automatically when allocations drift, and you get a notification every time something happens.
No watching tickers. No timing entries. No fat-finger mistakes at market open. You pick the portfolio, we do the work, your account follows along.
Pick the one that fits your risk level, or run all three:
Live portfolios, real positions, our own capital at stake. Your funds stay in your own brokerage account. Past performance doesn't guarantee future results.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
